A special section on CLINICAL PHARMACOLOGY is being planned for publication in the August 2023 issue of The Journal of Pharmacology and Experimental Therapeutics  

The full paper submission deadline is December 2022.  

A dedicated forum for original research on various aspects of clinical pharmacology, including but not limited to experimental and regulatory aspects of drug development, Phase I-II studies, therapeutic drug monitoring, pharmacokinetic and/or efficacy and safety issue in a special population (children, the elderly, multi-morbidity patients), population pharmacokinetics, pharmacogenomics, and personalized pharmacotherapies, advanced therapies (gene and cell therapy), bioinformatics.     

Original articles addressing any aspects of the aforementioned topics will be considered; please send presubmission inquiry to include the title, abstract, significance statement, and full author information to The Journal of Pharmacology and Experimental Therapeutics in advance of full submission. The guest editor, Dr. Giorgio Minotti, will review the presubmission inquiry, respond to the authors with comments, and assess whether final approval will be granted for a full submission. All submissions to the journal must refer to the journal Instructions to Authors (https://jpet.aspetjournals.org/content/ifora), where specific guidelines on research articles are located.